Journal: The Journal of investigative dermatology
Article Title: Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome.
doi: 10.1016/j.jid.2018.10.048
Figure Lengend Snippet: Figure 2. Dynamic ILC2s populations and cytokine expression in patients with DRESS. (a) The percentage of blood ILC2s with lymphoid gate was higher in the active stage in DRESS patients (n ¼ 15) than control subjects (n ¼ 15), and the number of blood ILC2s were decreased after steroid therapy at 4 weeks resolution phase. Furthermore, serum IL-5 (b), eotaxin (c), IL-33 (d), soluble ST2 (e), and TLSP (f) levels in DRESS patients from baseline to the 4-week follow-up are shown. DRESS, drug reaction with eosinophilia and systemic symptoms; ILC2, type 2 innate lymphoid cell; NS, not significant.
Article Snippet: Rabbit monoclonal anti-human TSLP antibody (GTX85059; Genetex, Irvine, CA), rabbit monoclonal anti-human IL-33 antibody (12372- 1-AP; Proteintech Rosemont, IL), and rabbit monoclonal anti- human ST2 antibody (11920-1-AP; Proteintech) were diluted 1:500 with antibody diluent and applied to the tissues for 30 mi- nutes at room temperature.
Techniques: Expressing, Control